Fisher information matrix for nonlinear mixed effects multiple response models: evaluation of the appropriateness of the first order linearization using a pharmacokinetic/pharmacodynamic model.
about
Implementation and evaluation of the SAEM algorithm for longitudinal ordered categorical data with an illustration in pharmacokinetics-pharmacodynamicsPopulation Fisher information matrix and optimal design of discrete data responses in population pharmacodynamic experiments.Population pharmacodynamic analysis of erythropoiesis in preterm infants for determining the anemia treatment potential of erythropoietin.Developing Exposure/Response Models for Anticancer Drug Treatment: Special ConsiderationsFPCA-based method to select optimal sampling schedules that capture between-subject variability in longitudinal studies.Individual Bayesian Information Matrix for Predicting Estimation Error and Shrinkage of Individual Parameters Accounting for Data Below the Limit of Quantification.Optimal sampling times for a drug and its metabolite using SIMCYP(®) simulations as prior information.Design optimisation for pharmacokinetic modeling of a cocktail of phenotyping drugs.Rapid sample size calculations for a defined likelihood ratio test-based power in mixed-effects models.Design evaluation and optimization for models of hepatitis C viral dynamics.Design evaluation and optimisation in crossover pharmacokinetic studies analysed by nonlinear mixed effects models.Influence of covariance between random effects in design for nonlinear mixed-effect models with an illustration in pediatric pharmacokinetics.Optimal design of clinical trials with biologics using dose-time-response models.Serial correlation in optimal design for nonlinear mixed effects models.Model-based analyses of bioequivalence crossover trials using the stochastic approximation expectation maximisation algorithm.
P2860
Q33743151-50B1AF9D-8C38-493B-BB80-BA62B715BD63Q33928776-146F888B-D6EA-4045-8F1E-EE7A162DF598Q36837971-38C7258F-DE94-4E6D-B670-1A9F810BF8E1Q38557331-333D2096-8F2B-4ECB-96CB-3476DCF40A09Q38686486-0661FA6C-A24B-4CC5-876D-B2DCA9D1C496Q38703261-53F5B612-2791-46AF-BBB9-234ED77641FDQ39508318-382ACA21-E94A-4802-AC98-75E1ED07E9A4Q40186641-030EC42C-DE36-4A34-991E-9FD020F9161EQ42546762-95AECA27-3808-4170-B894-613B09790BE9Q43034515-CFFF6137-3C1C-49BB-B3B7-718FE130E0D1Q45241474-F1119DE5-323D-4BB1-8518-1B67AF2B568DQ46058619-C577C6F6-8950-49C9-8194-5ACC8D171556Q51039918-BFDB12A8-0CD6-46C4-BD4C-5D8FD128E30EQ51403544-A8FA75A8-8580-4767-BA49-DA42D26BD652Q51544885-FD40A5C1-366F-468A-9919-EEDC2E002C8C
P2860
Fisher information matrix for nonlinear mixed effects multiple response models: evaluation of the appropriateness of the first order linearization using a pharmacokinetic/pharmacodynamic model.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Fisher information matrix for ...... kinetic/pharmacodynamic model.
@en
Fisher information matrix for ...... kinetic/pharmacodynamic model.
@nl
type
label
Fisher information matrix for ...... kinetic/pharmacodynamic model.
@en
Fisher information matrix for ...... kinetic/pharmacodynamic model.
@nl
prefLabel
Fisher information matrix for ...... kinetic/pharmacodynamic model.
@en
Fisher information matrix for ...... kinetic/pharmacodynamic model.
@nl
P2093
P2860
P356
P1476
Fisher information matrix for ...... kinetic/pharmacodynamic model.
@en
P2093
Caroline Bazzoli
France Mentré
Sylvie Retout
P2860
P304
P356
10.1002/SIM.3573
P407
P577
2009-06-01T00:00:00Z